News
DRTSW
2.100
-8.30%
-0.190
Major Insider Move at Alpha Tau Medical Shakes Up Investor Buzz
TipRanks · 1d ago
Alpha Tau Medical CFO Raphi Levy disposes of USD 220,002 Alpha Tau Medical common shares
PUBT · 2d ago
CFO’s Surprise Stock Move at Alpha Tau Medical Shakes Up Investor Buzz
TipRanks · 2d ago
Alpha Tau Medical Shareholders Back Board, CEO Dual Role and Auditor at June 2026 AGM
TipRanks · 3d ago
Alpha Tau Medical shareholders approve CEO Sofer to remain board chair
PUBT · 3d ago
Alpha Tau Medical CFO Raphi Levy disposes of 17,500 common shares valued at $167,055.5
PUBT · 3d ago
Alpha Tau Medical Continues Its Winning Streak with First-Ever Brain-Cancer Patient Treated Outside the U.S.
TipRanks · 4d ago
Alpha Tau treats first glioblastoma patient in Israel with Alpha DaRT
TipRanks · 5d ago
Alpha Tau Medical Announces Success Treatment With Alpha DaRT Of First Glioblastoma Patient In Israel
Benzinga · 5d ago
Alpha Tau treats first recurrent glioblastoma patient in Israel with Alpha DaRT under broad-access study
PUBT · 5d ago
Weekly Report: what happened at DRTS last week (0615-0619)?
Weekly Report · 6d ago
Largest borrow rate increases among liquid names
TipRanks · 06/17 12:45
Weekly Report: what happened at DRTS last week (0608-0612)?
Weekly Report · 06/15 09:31
Alpha Tau Granted FDA Clearance To Expand REGAIN Study For Alpha-DaRT In Glioblastoma Treatment
NASDAQ · 06/12 12:46
Alpha Tau Medical: A Lot Of Shots On Goal
Seeking Alpha · 06/12 12:13
Alpha Tau gets FDA clearance to complete enrollment in REGAIN trial
TipRanks · 06/11 13:17
Alpha Tau Wins FDA Clearance to Complete REGAIN Glioblastoma Trial Enrollment After Strong Interim Data
TipRanks · 06/11 12:57
Alpha Tau Medical Receives FDA Clearance To Proceed With Enrollment Of Final Seven Patients In U.S. REGAIN Trial
Benzinga · 06/11 12:33
Alpha Tau wins FDA clearance to complete enrollment in recurrent glioblastoma REGAIN trial
PUBT · 06/11 12:32
ALPHA TAU MEDICAL - TO RESUME RECRUITMENT FOR REMAINING SEVEN PATIENTS IN REGAIN TRIAL
Reuters · 06/11 12:30
More
Webull provides a variety of real-time DRTSW stock news. You can receive the latest news about Alpha Tau Medical Ltd through multiple platforms. This information may help you make smarter investment decisions.
About DRTSW
Alpha Tau Medical Ltd is an Israel-based medical technology company that focuses on research, development and commercialization of Alpha DaRT Diffusing Alpha-emitters Radiation Therapy (Alpha DaRT) for the treatment of solid cancer. Company's technology relies on the diffusion of atoms that emit alpha particles within the tumor tissue, and enables alpha radiation to reach the the entire tumor. Precise amounts of radioactive radium-224 affixed that emit short-range alpha radiation enables to damages and kills cancer cells within a short period of time. The Company has one subsidiary Healthcare Capital Corp.